Por favor, use este identificador para citar o enlazar a este item:
http://hdl.handle.net/10261/169584
COMPARTIR / EXPORTAR:
SHARE CORE BASE | |
Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL | DATACITE | |
Título: | Selective depletion of metastatic stem cells as therapy for human colorectal cancer |
Autor: | Céspedes, María Virtudes; Unzueta, Uguntz; Aviñó, Anna CSIC ORCID; Gallardo, Alberto; Álamo, Patricia; Sala, Rita; Sánchez-Chardi, Alejandro; Casanova, Isolda; Mangues, Maria Antònia; López-Pousa, Antonio; Eritja Casadellà, Ramón CSIC ORCID ; Villaverde, Antonio; Vázquez, Ramón; Mangues, Ramón | Palabras clave: | Colorectal cancer CXCR4 receptor Metastatic stem cells Protein nanoconjugate Targeted drug delivery |
Fecha de publicación: | 6-sep-2018 | Editor: | European Molecular Biology Organization | Citación: | EMBO Molecular Medicine e8772 (2018) | Resumen: | Selective elimination of metastatic stem cells (MetSCs) promises to block metastatic dissemination. Colorectal cancer (CRC) cells overexpressing CXCR4 display trafficking functions and metastasis‐initiating capacity. We assessed the antimetastatic activity of a nanoconjugate (T22‐GFP‐H6‐FdU) that selectively delivers Floxuridine to CXCR4+ cells. In contrast to free oligo‐FdU, intravenous T22‐GFP‐H6‐FdU selectively accumulates and internalizes in CXCR4+ cancer cells, triggering DNA damage and apoptosis, which leads to their selective elimination and to reduced tumor re‐initiation capacity. Repeated T22‐GFP‐H6‐FdU administration in cell line and patient‐derived CRC models blocks intravasation and completely prevents metastases development in 38–83% of mice, while showing CXCR4 expression‐dependent and site‐dependent reduction in foci number and size in liver, peritoneal, or lung metastases in the rest of mice, compared to free oligo‐FdU. T22‐GFP‐H6‐FdU induces also higher regression of established metastases than free oligo‐FdU, with negligible distribution or toxicity in normal tissues. This targeted drug delivery approach yields potent antimetastatic effect, through selective depletion of metastatic CXCR4+ cancer cells, and validates metastatic stem cells (MetSCs) as targets for clinical therapy. | Versión del editor: | https://doi.org/10.15252/emmm.201708772 | URI: | http://hdl.handle.net/10261/169584 | DOI: | 10.15252/emmm.201708772 |
Aparece en las colecciones: | (IQAC) Artículos |
Ficheros en este ítem:
Fichero | Descripción | Tamaño | Formato | |
---|---|---|---|---|
Selective depletion of metastatic stem cells as.pdf | 7,3 MB | Adobe PDF | Visualizar/Abrir |
CORE Recommender
PubMed Central
Citations
24
checked on 23-abr-2024
SCOPUSTM
Citations
66
checked on 19-abr-2024
WEB OF SCIENCETM
Citations
64
checked on 29-feb-2024
Page view(s)
348
checked on 23-abr-2024
Download(s)
338
checked on 23-abr-2024
Google ScholarTM
Check
Altmetric
Altmetric
Artículos relacionados:
NOTA: Los ítems de Digital.CSIC están protegidos por copyright, con todos los derechos reservados, a menos que se indique lo contrario.